Standard Biotools (LAB) Change in Acquisitions & Divestments (2011 - 2026)

Standard Biotools (LAB) has 14 years of Change in Acquisitions & Divestments data on file, last reported at $15.0 million in Q1 2026.

• Change in Acquisitions & Divestments for Q1 2026 came in at $15.0 million, down 71.15% year-over-year; the trailing twelve-month figure through Mar 2026 was $142.0 million (down 50.87% YoY), and the FY2025 annual result was $179.0 million, down 48.71% from the prior year.
• Change in Acquisitions & Divestments slipped to $15.0 million in Q1 2026 per LAB's latest filing, from $25.0 million in the prior quarter.
• Over five years, Change in Acquisitions & Divestments peaked at $127.0 million in Q2 2024 and troughed at $12.0 million in Q3 2022.
• A 5-year average of $51.0 million and a median of $49.0 million in 2024 frame the typical range for Change in Acquisitions & Divestments.
• The sharpest annual moves came in 2024 and 2026: Change in Acquisitions & Divestments soared 210.03% in 2024, then plunged 71.15% in 2026.
• A 5-year view of Change in Acquisitions & Divestments shows it stood at $41.0 million in 2022, then plunged by 36.59% to $26.0 million in 2023, then soared by 130.77% to $60.0 million in 2024, then slumped by 58.33% to $25.0 million in 2025, then plunged by 40.0% to $15.0 million in 2026.
• Business Quant data shows LAB's Change in Acquisitions & Divestments at $15.0 million in Q1 2026, $25.0 million in Q4 2025, and $54.0 million in Q3 2025.